Intervention not reported
Moderate to severe exacerbations ‐ HD TRIPLE vs HD‐ICS/LABA№ of participants: 4989(4 RCTs)
The intervention leads to lower moderate to severe exacerbations ‐ HD TRIPLE vs HD‐ICS/LABA№ of… (high certainty).
1 finding from 1 review
Intervention not reported
Moderate to severe exacerbations ‐ HD TRIPLE vs MD TRIPLE№ of participants: 3470(3 RCTs)
The intervention showed no clear difference in moderate to severe exacerbations ‐ HD TRIPLE vs MD TRIPLE№ of… (moderate certainty).
1 finding from 1 review
Intervention not reported
Moderate to severe exacerbations ‐ TRIPLE vs DUAL№ of participants: 8173(5 RCTs)
The intervention leads to lower moderate to severe exacerbations ‐ TRIPLE vs DUAL№ of participants:… (high certainty).
1 finding from 1 review
Death or moderate disability (mRS > 3) at 6 to 12 months · malignant cerebral oedema after ischaemic stroke
Summary of findings table ‐ surgical decompression probably leads to lower death or moderate disability (mRS > 3) at 6 to 12 months compared with medical treatment alone (moderate certainty).
1 finding from 1 review
Moderate‐severe nasal injury · preterm infants receiving nasal CPAP
Mask may leads to lower moderate–severe nasal injury compared with prongs (low certainty).
1 finding from 1 review
Exacerbations: number of people experiencing moderate or severe exacerbations · treatment for asthma in adults and children with asthma and GORD
Medical or surgical intervention, or both, for gastro‐oesophageal… showed no clear difference in number of participants with moderate/severe acute exacerbations… compared with nil intervention, delayed intervention control, or placebo (low certainty).
1 finding from 1 review
Cosmetic appearance · participants with varicose veinsa
1 finding from 1 review
Intervention not reported
MMRV randomised controlled trial ‐ moderate/severe cases ‐ 2 doses ‐ · children 9 months to 15 years old
The intervention leads to lower MMRV randomised controlled trial ‐ moderate/severe cases ‐ 2 doses ‐ (high certainty).
1 finding from 1 review
Intervention not reported
MMRV randomised controlled trial ‐ moderate/severe cases ‐ 2 doses ‐ · children 9 months to 15 years old
The intervention leads to lower MMRV randomised controlled trial ‐ moderate/severe cases ‐ 2 doses ‐ (high certainty).
1 finding from 1 review
Intervention not reported
MMRV randomised controlled trial ‐ moderate/severe cases ‐ 2 doses ‐ · children 9 months to 15 years old
The intervention leads to lower MMRV randomised controlled trial ‐ moderate/severe cases ‐ 2 doses ‐ (high certainty).
1 finding from 1 review
Intervention not reported
MMR+V randomised controlled trial ‐ moderate/severe cases ‐ 2 doses ‐ · children 9 months to 15 years old
The intervention leads to lower MMR+V randomised controlled trial ‐ moderate/severe cases ‐ 2 doses ‐ (high certainty).
1 finding from 1 review
Intervention not reported
MMR+V randomised controlled trial ‐ moderate/severe cases ‐ 2 doses ‐ · children 9 months to 15 years old
The intervention leads to lower MMR+V randomised controlled trial ‐ moderate/severe cases ‐ 2 doses ‐ (high certainty).
1 finding from 1 review
Intervention not reported
MMR+V randomised controlled trial ‐ moderate/severe cases ‐ 2 doses ‐ · children 9 months to 15 years old
The intervention leads to lower MMR+V randomised controlled trial ‐ moderate/severe cases ‐ 2 doses ‐ (high certainty).
1 finding from 1 review
Intervention not reported
Cohort studies ‐ autism risk (moderate/high), MMR · children 9 months to 15 years old
The intervention may leads to lower cohort studies ‐ autism risk (moderate/high), MMR (low certainty).
1 finding from 1 review
OHSS · Women undergoing ovarian stimulation with gonadotrophins in IVF and ICSI procedures
Monitoring ovarian stimulation by transvaginal ultrasound (TVUS) only showed no clear difference in OHSS rate (mild, moderate or severe) per woman compared with monitoring with TVUS plus serum estradiol (low certainty).
1 finding from 1 review
Severity of attacks · primary Raynaud's phenomenon
1 finding from 1 review
Intervention not reported
Moderate to vigorous physical activity (minutes/d) [ · children and adolescents aged 6 to 18 years
1 finding from 1 review
Moderate or severe OHSS · women undergoing assisted reproduction
Dopamine agonist probably leads to lower incidence of moderate or severe OHSS compared with placebo/no intervention (moderate certainty).
1 finding from 1 review
Moderate or severe OHSS · women undergoing assisted reproduction
It is very uncertain whether dopamine agonist changes incidence of moderate or severe OHSS compared with other active intervention (very low certainty).
1 finding from 1 review
Moderate or severe OHSS · women undergoing assisted reproduction
Dopamine agonist plus co‐intervention may leads to lower incidence of moderate or severe OHSS compared with co‐intervention (low certainty).
1 finding from 1 review